Clinical Trials Logo
  1. Home
  2. Placebo Effect
  3. NCT03694886

The Effect of Tablet Size on Cognitive Performance Caffeine — CaC  

Placebo Effect Clinical Trial

Official title:
The Effect of Tablet Size on Cognitive Performance: A Randomized Control Trial Using Caffeine

Clinical Trial Summary

This study aims to assess if tablet size, due to placebo effect, alters participants' performance on cognitive tests after consuming caffeine. Participants will be randomly assigned to one of four groups: 1) 90 mg caffeine with a 1 mm diameter sucrose pillule; 2) no caffeine with the small sucrose pillule; 3) 90 mg caffeine with a 5 mm sucrose pillule; 4) no caffeine with the large sucrose pillule.

Clinical Trial Description

Background: A capsule's physical design (e.g. shape, size, and color) affects individuals' perception of drug efficacy; that is, how well a drug is likely to work. The goal of this study is to assess the effects tablet size may have on participant's performance on cognitive testing since research has found differences between preparation methods. Method: 120 participants will be randomly assigned to one of four groups: 1) 90 mg caffeine with a 1 mm diameter sucrose pillule; 2) no caffeine with the small sucrose pillule; 3) 90 mg caffeine with a 5 mm sucrose pillule; 4) no caffeine with the large sucrose pillule. Participants will consume the designated placebo tablet with water (caffeinated or non-caffeinated); then, participants will provide weekly caffeine intake and complete the neutral portion of Velten's Mood Induction Procedure until 30 minutes have passed to allow for caffeine activation. Participants will complete the Stroop test, Trial Making Tests A and B, and the Rey Auditory Verbal Learning Test. Previous literature, as far as the author knows, relied on evaluating drug efficacy based on appearance alone. This study aims to assess if tablet size, due to placebo effect, alters participants' performance on cognitive tests after consuming caffeine. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03694886
Study type Interventional
Source University of Colorado, Denver
Contact
Status Completed
Phase Phase 4
Start date October 31, 2018
Completion date March 1, 2019
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04650841 - The Role of the Opioid System in Placebo Effects on Pain and Social Rejection Early Phase 1
Not yet recruiting NCT04646460 - Context Interventions: Social Modeling and Initial Treatment Experience N/A
Completed NCT04571827 - The Influence of Expectations on Post-needling Soreness and Pain Processing After Dry Needling Treatment N/A
Completed NCT01501591 - Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size N/A
Completed NCT02802241 - Effects of Open-label vs Double-blind Treatment in IBS N/A
Not yet recruiting NCT06423365 - A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication. N/A
Completed NCT03017534 - Non-Specific Effects of Manual Therapy N/A
Completed NCT02578420 - Back to Basics - Effects, Narratives and Routes of Administration of Open-label Placebo N/A
Completed NCT02578212 - Trust Game and Placebo Response N/A
Completed NCT00426010 - Measuring Placebo Effect by Elimination and Investigating Mechanism of Action N/A
Completed NCT02365220 - Smartphone Application, Mood and Stress N/A
Completed NCT01501747 - The Placebo Effect May Involve Modulating Drug Bioavailability N/A
Recruiting NCT04766580 - Attention and Pain in Children With and Without Attention Deficit and/or Hyperactivity Disorder N/A
Completed NCT05004467 - Clinical Predictive Effects of Mulligan Treatment in Patients With Chronic Neck Pain N/A
Recruiting NCT03950999 - Experimental Pain Reporting Accuracy and Placebo Response N/A